Angelalign to Appeal Chinese Patent Judgment
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Angelalign’s court-ordered halt on two digital planning systems in China could delay or restrict treatment planning for orthodontists and aligner providers who rely on the A7 and A7 Speed premolar-extraction workflows, affecting both clinical efficiency and case throughput.
Key points
- The Jinan Intermediate People’s Court ruling bars Angelalign’s Chinese subsidiaries from using the masterForce biomechanics simulation and ATreat digital diagnosis systems for premolar-extraction aligner cases.
- Angelalign plans to appeal the August 10 decision, so the injunction is not yet final and may be lifted or modified.
- Specialists and DSOs offering clear-aligner therapy in China may face temporary workflow changes or have to switch to alternative digital planning software while the appeal proceeds.
- No impact has been reported outside mainland China; U.S. and EU users of Angelalign products are unaffected at this time.
Who should care
Read the original on Dentistry Today
Full reporting and any paywall content live on dentistrytoday.com. We summarize and score; we do not republish.
Related
- ·Business
Why the dental assistant shortage could get worse
- ·Business
US Oral Surgery Management exec on M&A: ‘We’ve had to be even more disciplined’
- ·Research
Vertical dimension of occlusion restoration using a digital injectable composite resin technique: A 5-year clinical follow-up
- ·Research
A digitally guided workflow integrating tooth preparation and restoration positioning for minimally invasive veneer and partial-coverage restorations: A dental technique